These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12659372)

  • 1. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
    Giglio P
    South Med J; 2003 Mar; 96(3):320-1. PubMed ID: 12659372
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic epidermal necrolysis as a complication of treatment with celecoxib.
    Perna AG; Woodruff CA; Markus RF; Hsu S
    Dermatol Online J; 2003 Dec; 9(5):25. PubMed ID: 14996398
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxic epidermal necrolysis and celecoxib (Celebrex)].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2004 Jan; 131(1 Pt 1):107. PubMed ID: 15041861
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic epidermal necrolysis after celecoxib therapy.
    Berger P; Dwyer D; Corallo CE
    Pharmacotherapy; 2002 Sep; 22(9):1193-5. PubMed ID: 12222558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimesulide-induced hepatitis and toxic epidermal necrolysis.
    Chatterjee S; Pal J; Biswas N
    J Postgrad Med; 2008; 54(2):150-1. PubMed ID: 18480536
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
    Wolf R; Matz H; Marcos B; Orion E
    Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe cutaneous drug reactions to celecoxib (Celebrex)].
    Marquès S; Milpied B; Foulc P; Barbarot S; Cassagnau E; Stalder JF
    Ann Dermatol Venereol; 2003 Nov; 130(11):1051-5. PubMed ID: 14724542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
    Friedman B; Orlet HK; Still JM; Law E
    South Med J; 2002 Oct; 95(10):1213-4. PubMed ID: 12425513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allergic vasculitis following ingestion of celecoxib?].
    Gscheidel D; Daspet MK; Le Coz CJ; Lipsker D
    Hautarzt; 2002 Jul; 53(7):488-91. PubMed ID: 12219273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic skin reaction to celecoxib.
    Grob M; Scheidegger P; Wüthrich B
    Dermatology; 2000; 201(4):383. PubMed ID: 11146365
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far.
    Goeschke B; Braathen LR
    Dermatology; 2004; 209(1):53-6. PubMed ID: 15237269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic vasculitis associated with celecoxib.
    Jordan KM; Edwards CJ; Arden NK
    Rheumatology (Oxford); 2002 Dec; 41(12):1453-5. PubMed ID: 12468830
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apropos of A. A. Kalamkarian and V. A. Samsonov's article, "Erythema multiforme exudativum, the Stevens-Johnson Syndrome, toxic epidermal necrolysis (Lyell's Syndrome) and their interrelationship"].
    Brailovskiĭ AIa
    Vestn Dermatol Venerol; 1980 Nov; (11):29-31. PubMed ID: 7445718
    [No Abstract]   [Full Text] [Related]  

  • 17. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
    Wooltorton E
    CMAJ; 2002 Jun; 166(13):1692-3. PubMed ID: 12126328
    [No Abstract]   [Full Text] [Related]  

  • 18. [Occurrence of the Stevens-Johnson syndrome (erythema exudativum multiforme) and severe skin reactions with relation to sulfonamide therapy. Reply to questions sent to a Norwegian hospital].
    Tidsskr Nor Laegeforen; 1966 Sep; 86(17):1207-9. PubMed ID: 4224656
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug eruptions caused by sulphonamides].
    Kuokkanen K; Palatsi R
    Duodecim; 1971; 87(5):362-6. PubMed ID: 4252615
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lyell's syndrome (toxic epidermal necrolysis) and its relation to the Stevens-Johnson pluri-orificial syndrome. Attribution of both syndromes to the use of drugs, with special reference to delayed-action sulfonamides].
    De Toni E
    Minerva Med; 1962 Oct; 53():3189-204. PubMed ID: 14026097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.